Status:
TERMINATED
Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients
Lead Sponsor:
Maimonides Medical Center
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine whether buprenorphine can be at least as effective as other opioid medications in relieving chronic pain in patients who suffer from dependence on their opioid ...
Detailed Description
The study will utilize sublingual buprenorphine for the treatment of chronic pain patients with co-occurring opioid dependence. Adult male and female chronic pain patients with co-occurring opioid dep...
Eligibility Criteria
Inclusion
- Meets DSM criteria for opioid dependence (or opioid use disorder when DSM 5 is in use)
- Has received opioid therapy for at least 90 days
- Has opioid dependence as assessed by a Maimonides psychiatrist
Exclusion
- Scheduled for major surgery during study duration
- Predicted life expectancy \< 1 year
- Plan to cease habitation in greater New York area within 6 months
- Risks for buprenorphine outweigh potential benefit, as determined by the PI
- Lacks sufficient fluency in English to understand the study protocol, answer survey questions or give informed consent
- Pregnant women
Key Trial Info
Start Date :
February 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01841931
Start Date
February 1 2013
End Date
August 1 2013
Last Update
April 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maimonides Medical Center
Brooklyn, New York, United States, 11219